HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $881,000 | +16.7% | 53,200 | 0.0% | 0.00% | – |
| Q1 2018 | $755,000 | -2.8% | 53,200 | 0.0% | 0.00% | – |
| Q4 2017 | $777,000 | +15.1% | 53,200 | 0.0% | 0.00% | – |
| Q3 2017 | $675,000 | -96.6% | 53,200 | -96.8% | 0.00% | -100.0% |
| Q2 2017 | $19,882,000 | +0.3% | 1,674,990 | +24.9% | 0.01% | 0.0% |
| Q1 2017 | $19,824,000 | -6.5% | 1,341,290 | +2.3% | 0.01% | -9.1% |
| Q4 2016 | $21,211,000 | -20.6% | 1,310,990 | -11.1% | 0.01% | -21.4% |
| Q3 2016 | $26,726,000 | +5.5% | 1,474,100 | -4.2% | 0.01% | 0.0% |
| Q2 2016 | $25,340,000 | +19.8% | 1,538,570 | +20.5% | 0.01% | +27.3% |
| Q1 2016 | $21,155,000 | +3952.7% | 1,276,730 | +5195.9% | 0.01% | – |
| Q4 2015 | $522,000 | -97.2% | 24,108 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $18,756,000 | – | 946,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |